540 related articles for article (PubMed ID: 9689154)
1. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients.
Bonomini M; Reale M; Santarelli P; Stuard S; Settefrati N; Albertazzi A
Nephron; 1998 Aug; 79(4):399-407. PubMed ID: 9689154
[TBL] [Abstract][Full Text] [Related]
2. Circulating soluble adhesion molecules in ANCA-associated vasculitis.
Ara J; Mirapeix E; Arrizabalaga P; Rodriguez R; Ascaso C; Abellana R; Font J; Darnell A
Nephrol Dial Transplant; 2001 Feb; 16(2):276-85. PubMed ID: 11158400
[TBL] [Abstract][Full Text] [Related]
3. Soluble adhesion molecules in children and young adults on chronic hemodialysis.
Musiał K; Zwolińska D; Polak-Jonkisz D; Berny U; Szprynger K; Szczepańska M
Pediatr Nephrol; 2004 Mar; 19(3):332-6. PubMed ID: 14745633
[TBL] [Abstract][Full Text] [Related]
4. Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure.
Musiał K; Zwolińska D; Polak-Jonkisz D; Berny U; Szprynger K; Szczepańska M
Pediatr Nephrol; 2005 Jan; 20(1):52-5. PubMed ID: 15602666
[TBL] [Abstract][Full Text] [Related]
5. Soluble adhesion molecules in children and young adults with chronic renal failure treated conservatively.
Musiał K; Zwolińska D; Berny U; Polak-Jonkisz D; Szprynger K; Szczepańska M
Rocz Akad Med Bialymst; 2004; 49():209-12. PubMed ID: 15631345
[TBL] [Abstract][Full Text] [Related]
6. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure.
Mrowka C; Sieberth HG
Clin Nephrol; 1995 May; 43(5):288-96. PubMed ID: 7543387
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of soluble TNF-alpha receptors and cellular adhesion molecules in patients undergoing bioincompatible hemodialysis.
Rysz J; Majewska E; Stolarek RA; Banach M; Ciałkowska-Rysz A; Baj Z
Am J Nephrol; 2006; 26(5):437-44. PubMed ID: 16988495
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic values of adhesion molecules VCAM-1, ICAM-1 and C-reactive protein in Egyptian patients with chronic kidney disease.
Attalah MF; Adel LA; Fahmy DE
Egypt J Immunol; 2011; 18(2):59-66. PubMed ID: 23082471
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.
Bolton CH; Downs LG; Victory JG; Dwight JF; Tomson CR; Mackness MI; Pinkney JH
Nephrol Dial Transplant; 2001 Jun; 16(6):1189-97. PubMed ID: 11390719
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
Małyszko J; Małyszko JS; Myśliwiec M
Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
[TBL] [Abstract][Full Text] [Related]
13. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
Mrowka C; Heintz B; Sieberth HG
Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
[TBL] [Abstract][Full Text] [Related]
14. Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients.
Kahraman S; Yilmaz R; Kirkpantur A; Genctoy G; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
Nephrology (Carlton); 2005 Jun; 10(3):264-9. PubMed ID: 15958039
[TBL] [Abstract][Full Text] [Related]
15. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.
Wenisch C; Myskiw D; Gessl A; Graninger W
J Clin Endocrinol Metab; 1995 Jul; 80(7):2122-6. PubMed ID: 7541802
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
[TBL] [Abstract][Full Text] [Related]
17. Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients.
Rabb H; Calderon E; Bittle PA; Ramirez G
Am J Kidney Dis; 1996 Feb; 27(2):239-43. PubMed ID: 8659500
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of circulating vascular endothelial growth factor and soluble adhesion molecules as reliable predictors of native arteriovenous fistula thrombosis in chronic hemodialysis patients.
Zohny SF; Abd el-Fattah M
Clin Biochem; 2008 Oct; 41(14-15):1175-80. PubMed ID: 18692491
[TBL] [Abstract][Full Text] [Related]
19. [Soluble cell adhesion molecules in chronic renal graft rejection].
Boratyńska M
Pol Arch Med Wewn; 1998 Nov; 100(5):410-8. PubMed ID: 10410574
[TBL] [Abstract][Full Text] [Related]
20. Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients.
Peng YS; Chiang CK; Hsu SP; Pai MF; Hung KY; Kao JH
Blood Purif; 2005; 23(2):106-12. PubMed ID: 15640602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
